Provided by Tiger Trade Technology Pte. Ltd.

Genmab A/S

37.07
+1.022.83%
Post-market: 37.070.00000.00%16:10 EDT
Volume:2.33M
Turnover:86.10M
Market Cap:22.80B
PE:29.30
High:37.15
Open:36.55
Low:36.33
Close:36.05
52wk High:40.17
52wk Low:23.62
Shares:615.00M
Float Shares:576.00M
Volume Ratio:0.35
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.54
ROE:14.00%
ROA:8.79%
PB:3.83
PE(LYR):24.12

Loading ...

Genmab A/S Stock Rises Friday, Outperforms Market

Dow Jones
·
4 hours ago

Genmab (GMAB) Receives a Buy from Truist Financial

TIPRANKS
·
Yesterday

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Oct 08

Genmab Price Target Raised to $50.00/Share from $40.00 by HC Wainwright & Co.

Dow Jones
·
Oct 07

U.S. Futures Increase, European Stocks Up

Dow Jones
·
Oct 06

Genmab, AbbVie Say New Drug Combo Helps Lymphoma Patients Stay Cancer-Free Longer

MT Newswires Live
·
Oct 06

Genmab A/S Stock (GMAB) Moved Up by 13.01% on Oct 5: Key Drivers Unveiled

TradingKey
·
Oct 06

Movement Alert|Genmab A/S Intraday Rise 11.11%, Rina-S Ovarian Cancer Trial Shows 45.9% Response Rate

Market Focus
·
Oct 06

Genmab, AbbVie report epcoritamab combination demonstrates improved PFS in study

TIPRANKS
·
Oct 06

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Oct 06

Genmab is Maintained at Buy by Guggenheim

Dow Jones
·
Oct 05

Analysts Conflicted on These Healthcare Names: Pfizer (PFE) and Genmab (GMAB)

TIPRANKS
·
Oct 05

Genmab Reports 45.9% Response Rate for Rina-S in Ovarian Cancer Trial

MT Newswires Live
·
Oct 05

Genmab : Guggenheim Raises Target Price to $54 from $45

THOMSON REUTERS
·
Oct 05

Genmab announces Rina-S Phase 2 RAINFOL-1 trial results

TIPRANKS
·
Oct 05

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Oct 03

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Oct 01

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 29

Genmab A/S Stock Falls Thursday, Outperforms Market

Dow Jones
·
Sep 25

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Sep 24